Breaking News Headlines Today

News about Merck

Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 155 stories have been published about Merck which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Merck News

Donald Trump · United States

Stock Market Today: Dow, S&P 500, Nasdaq Slip; Trump Ukraine Meeting; Nvidia, Intel, UnitedHealth, and More Movers

100% Center coverage: 3 sources

The Dow, S&P 500, and Nasdaq are falling as the stock market braces for President Donald Trump's Ukraine meeting.See the Story

Merck

IO Bio Plans Cancer Vaccine Filing Despite Trial Miss

100% Center coverage: 2 sources

IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless.See the Story

Cancer · Bamberg

Merck Receives Approval for Cancer After Billions of Dollars

100% Center coverage: 1 sources

After the largest pharmaceutical acquisition in decades, Merck can achieve success. The EU is giving approval to a cancer drug against rare tumours - good news for affected patients.See the Story

European Commission Grants Approval of OGSIVEO® (Nirogacestat) for the Treatment of Adults with ...

100% Center coverage: 1 sources

STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an oral gamma secretase inhibitor, as monotherapy for…European Union See the Story

'AR will be killer app of AI,' Merck OLED head says

100% Left coverage: 1 sources

The global tech industry is shifting its focus from advancing artificial intelligence (AI) models to maximizing their impact through real-world user applications. Johannes Canisius, general manager of Merck’s OLED (organic light-emitting diode) business, predicted that augmented reality (AR) will emerge as the next “killer application” for AI, stressing that achieving this vision will require breakthrough materials and strategic collaborations w…Artificial Intelligence · Seoul Read Article

AAIC 2025 Preclinical Results of Anti-Tau Antibody MK-2214 in Alzheimer Disease: Jonathan Sugam, PhD

The principal scientist of neuroscience discovery at Merck presented preclinical data at AAIC 2025 supporting the development of MK-2214, an anti-tau antibody designed to slow or prevent the progression of AD. [WATCH TIME: 5 minutes]Merck Read Article

2 Top Dividend Stocks to Buy on the Dip @themotleyfool #stocks $PFE $MRK

100% Left coverage: 1 sources

Key PointsPfizer's pipeline in oncology, combined with its cost-cutting initiatives, could help it bounce back.Merck could move beyond Keytruda thanks to newer approvals and a novel formulation of the medicine.Both companies have increased their dividends at a decent rate over the past five years. 10 stocks we like better than Pfizer › Dividend stocks are a great investment choice for many reasons. Buying on the dip is even better, provided, of …Merck · United States Read Article

3 Magnificent S&P 500 Dividend Stocks Down Roughly 26% to 60% to Buy and Hold Forever @themotleyfool #stocks $TGT $^GSPC $MRK $PEP

100% Left coverage: 1 sources

Key PointsShares of Merck are down thanks to Keytruda's impending loss of patent protection, but the drugmaker's pipeline is still pretty compelling.There's a chance the economic lethargy that's working against retailer Target is about to dissipate.Snack chip and beverage giant PepsiCo's pronounced vulnerability to higher prices won't be a problem forever.10 stocks we like better than Target › The past several months have been bullish ones for t…S&P 500 · United States Read Article

Drugmakers form new group to lobby on impact of Medicare drug price negotiations

100% Center coverage: 1 sources

The members of IRA Watchdog are Merck, AstraZeneca, Bristol Myers Squibb Company, and Eli Lilly, according to lobbying disclosure records.Merck · United States Read Article

Pembrolizumab Becomes First Approved Perioperative Immunotherapy for Resectable HNSCC in Canada

Merck's pembrolizumab gains Health Canada approval for innovative perioperative treatment of advanced head and neck squamous cell carcinoma, enhancing patient outcomes.Merck · Canada Read Article

Building a collaborative executive comms strategy - Ragan Communications

Tips from Merck’s leadership comms approach. A smart executive communications strategy can be the difference between chaos in a crisis and grounded trust. It’s an internal communicator’s job to have the processes and steps in place to help leaders hit the right notes when it’s their opportunity to speak. At Ragan’s Employee Communication and Culture Conference earlier this year, Melissa Moody, director of corporate communications at Merck, said …Merck · Rahway Read Article

News about Merck

News about Merck

Covered Most By

Local News Publishers

Top Merck News

Stock Market Today: Dow, S&P 500, Nasdaq Slip; Trump Ukraine Meeting; Nvidia, Intel, UnitedHealth, and More Movers

IO Bio Plans Cancer Vaccine Filing Despite Trial Miss

Merck Receives Approval for Cancer After Billions of Dollars

European Commission Grants Approval of OGSIVEO® (Nirogacestat) for the Treatment of Adults with ...

'AR will be killer app of AI,' Merck OLED head says

AAIC 2025 Preclinical Results of Anti-Tau Antibody MK-2214 in Alzheimer Disease: Jonathan Sugam, PhD

2 Top Dividend Stocks to Buy on the Dip @themotleyfool #stocks $PFE $MRK

3 Magnificent S&P 500 Dividend Stocks Down Roughly 26% to 60% to Buy and Hold Forever @themotleyfool #stocks $TGT $^GSPC $MRK $PEP

Drugmakers form new group to lobby on impact of Medicare drug price negotiations

Pembrolizumab Becomes First Approved Perioperative Immunotherapy for Resectable HNSCC in Canada

Building a collaborative executive comms strategy - Ragan Communications

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Merck

European Commission Grants Approval of OGSIVEO® (Nirogacestat) for the Treatment of Adults with ...

'AR will be killer app of AI,' Merck OLED head says

AAIC 2025 Preclinical Results of Anti-Tau Antibody MK-2214 in Alzheimer Disease: Jonathan Sugam, PhD

2 Top Dividend Stocks to Buy on the Dip @themotleyfool #stocks $PFE $MRK

3 Magnificent S&P 500 Dividend Stocks Down Roughly 26% to 60% to Buy and Hold Forever @themotleyfool #stocks $TGT $^GSPC $MRK $PEP

Drugmakers form new group to lobby on impact of Medicare drug price negotiations

Pembrolizumab Becomes First Approved Perioperative Immunotherapy for Resectable HNSCC in Canada

Building a collaborative executive comms strategy - Ragan Communications